Gene Therapy/Gene Editing Program

About Tiba Biotech

Founded in 2020 and based in Cambridge, Massachusetts, Tiba Biotech is a private, preclinical biotech emerging from a 5-year sponsored research program at M.I.T. and the Whitehead Institute. The company is developing a proprietary RNA platform that integrates a novel, biodegradable delivery nanoparticle with advanced computational RNA design, aiming to create safer and more potent vaccines and therapeutics. With a seasoned leadership team and backing from global foundations and government partners like NIH, BARDA, and CEPI, Tiba is initially targeting influenza vaccines while building a pipeline in oncology and genetic medicines.

Therapeutic Areas

Other Genetic Diseases Drugs